- Home
- HSTM vs IMTX Comparison
HSTM vs IMTX Comparison
Compare HSTM & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSTM
- IMTX
- Stock Information
- Founded
- HSTM 1990
- IMTX N/A
- Country
- HSTM United States
- IMTX Germany
- Employees
- HSTM N/A
- IMTX N/A
- Industry
- HSTM Computer Software: Programming Data Processing
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HSTM Technology
- IMTX Health Care
- Exchange
- HSTM Nasdaq
- IMTX Nasdaq
- Market Cap
- HSTM 864.6M
- IMTX 865.5M
- IPO Year
- HSTM 2000
- IMTX N/A
- Fundamental
- Price
- HSTM $26.95
- IMTX $9.39
- Analyst Decision
- HSTM Hold
- IMTX Strong Buy
- Analyst Count
- HSTM 2
- IMTX 5
- Target Price
- HSTM $28.00
- IMTX $15.00
- AVG Volume (30 Days)
- HSTM 191.3K
- IMTX 815.8K
- Earning Date
- HSTM 10-20-2025
- IMTX 11-17-2025
- Dividend Yield
- HSTM 0.46%
- IMTX N/A
- EPS Growth
- HSTM 14.03
- IMTX N/A
- EPS
- HSTM 0.67
- IMTX N/A
- Revenue
- HSTM $295,211,000.00
- IMTX $152,823,253.00
- Revenue This Year
- HSTM $4.90
- IMTX N/A
- Revenue Next Year
- HSTM $5.12
- IMTX N/A
- P/E Ratio
- HSTM $40.24
- IMTX N/A
- Revenue Growth
- HSTM 3.50
- IMTX 83.61
- 52 Week Low
- HSTM $25.36
- IMTX $3.30
- 52 Week High
- HSTM $34.24
- IMTX $11.40
- Technical
- Relative Strength Index (RSI)
- HSTM 35.07
- IMTX 78.64
- Support Level
- HSTM $27.04
- IMTX $6.90
- Resistance Level
- HSTM $27.94
- IMTX $9.54
- Average True Range (ATR)
- HSTM 0.56
- IMTX 0.47
- MACD
- HSTM -0.29
- IMTX 0.25
- Stochastic Oscillator
- HSTM 1.09
- IMTX 95.21
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.